Latest News

Felicia Johnson, who is living with metastatic disease, and Sharon Rivera-Sanchez, who was diagnosed in 2015 with triple-negative breast cancer, talk about what they learned during the GRASP (Guiding Researchers & Advocates to Scientific Partnerships) program.

​

Many people have never heard of triple negative breast cancer (TNBC), and Sharon Rivera-Sanchez was one of them, until she was diagnosed with it.

TNBC is a type of breast cancer that does not have any of the three most common receptors that fuel breast cancer growth, making it difficult to treat because the tumor can't be directly targeted

NCCS’ Fall ‘19 roundtable hosted key decision-makers and industry experts that helped identify 2020 policy objectives. The panelists suggested potential approaches to eliminating economic barriers such as creating “competition” among clinical trials’ sponsors about their achievement of enrollment diversity.